Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-17T00:48:43.197Z Has data issue: false hasContentIssue false

Untapped potential: exploring clinical pharmacists as antibiotic stewardship ambassadors

Published online by Cambridge University Press:  28 April 2025

Esther Esadah
Affiliation:
Department of Pharmacy, Children’s National Hospital, Washington, DC, USA
Hayden T. Schwenk*
Affiliation:
Department of Pediatrics, Division of Infectious Diseases, Stanford School of Medicine, Stanford, CA, USA
Laura L. Bio
Affiliation:
Department of Pharmacy, Lucile Packard Children’s Hospital Stanford, Palo Alto, CA, USA
*
Corresponding author: Hayden T. Schwenk; Email: hschwenk@stanford.edu

Abstract

Objective:

To describe inpatient clinical pharmacists’ interventions on injectable antibiotics and assess their impact on prospective audit and feedback (PAF) by the antimicrobial stewardship program (ASP).

Design:

Retrospective cohort study.

Setting:

Freestanding, quaternary-care, pediatric and obstetric hospital.

Methods:

We identified all clinical pharmacist interventions (iVents) documented on injectable antibiotics from November 1, 2020, through October 31, 2022. PAF performed on injectable antibiotics during the same timeframe was captured. We reported characteristics of clinical pharmacist iVents on injectable antibiotics. We also compared the incidence of PAF recommendations (PAFR) between PAF cases with prior iVent documentation for the same patient and antibiotic and those without preceding iVent documentation.

Results:

A total of 5,277 iVents were documented on injectable antibiotic orders. Cefazolin had the highest volume of iVents (13%). Antibiotic dose optimization was the most frequent iVent type (34%). A total of 5,152 PAF were documented by ASP pharmacists on injectable antibiotics during the study period, with 1,782 (34%) resulting in a PAFR. A total of 999 PAF (19%) had a prior iVent; 4,153 PAF did not. Comparing the two groups, the incidence of a PAFR was significantly higher in the PAF with prior iVent group compared to the PAF without prior iVent group (383/999, 38% vs 1,399/ 4,153, 34%; P = 0.006). Antibiotic discontinuation was the most common type of PAFR in both groups.

Conclusions:

Clinical pharmacists serve as ASP ambassadors, intervening on injectable antibiotic orders to improve prescribing. Future efforts to expand and incorporate clinical pharmacists in ASP initiatives are warranted.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Distribution of iVents by unit type

Figure 1

Table 2.Comparison of iVents and antimicrobial stewardship program pharmacist PAFR, by antibiotic

Figure 2

Figure 1.Flowchart of iVent screening.

Figure 3

Table 3.Type of prospective audit and feedback recommendation in the presence and absence of prior iVents

Supplementary material: File

Esadah et al. supplementary material 1

Esadah et al. supplementary material
Download Esadah et al. supplementary material 1(File)
File 331.7 KB
Supplementary material: File

Esadah et al. supplementary material 2

Esadah et al. supplementary material
Download Esadah et al. supplementary material 2(File)
File 336.8 KB
Supplementary material: File

Esadah et al. supplementary material 3

Esadah et al. supplementary material
Download Esadah et al. supplementary material 3(File)
File 23.6 KB